4 results
Approved WMOCompleted
To determine the toxicity of adding chloroquine in escalating doses in patients with small cell lung cancer to standard therapy.
Approved WMOCompleted
To determine the toxicity of adding chloroquine in escalating doses in patients with small cell lung cancer to standard therapy.
Approved WMORecruiting
Primary objective:- To assess the long-term safety and tolerability of efgartigimod PH20 SC (efgartigimod co formulated with recombinant human hyaluronidase PH20 [rHuPH20] for subcutaneous [SC] administration).Secondary objectives:- To determine theā¦
Approved WMORecruiting
The objective of the study is to assess the long-term safety and efficacy of intravenous ATB200 co-administration with oral AT2221 in adult subjects with late-onset Pompe disease.